The OHDSI community prides itself on global collaboration through open science. As a virtual community with collaborators on six different continents, we have weekly meetings to present research, share information, and keep each other updated on both current and upcoming projects. We hold these meetings on Tuesdays at 11 am ET in our Microsoft Teams environment. If you don’t have access to this, please fill out this form.
You can learn about our weekly calls, including the upcoming schedule of topics, and see materials (videos/slides/shoutouts) from previous calls by visiting our Community Calls page.
OHDSI has a variety of ongoing projects led by workgroups. Each workgroup has its own leadership team which determines the project’s objectives, goals and artifacts to be contributed to the community. Workgroup participation is open to all who have an interest in contributing to the project objectives and goals. Workgroups may be long-standing, strategic objectives or short-term projects to accomplish a specific need in the community. Each of the workgroups has its own home in the Teams environment, and you can get access to these groups by filling out this form (please note that you must have Teams access first, which is available through the first form linked above).
Please use our Upcoming Workgroup Calls page to see the upcoming schedule of calls (and appropriate links), as well as the standard schedule of calls for each group (weekly, bi-weekly, monthly, etc.).
We hope you will bring your talents, interests, curiosity and enthusiasm to OHDSI by joining both our weekly community calls and the workgroups that most interest you. That is how you #JoinTheJourney!
WEEKLY UPDATE • April 6, 2021
The April 6 OHDSI Community Call focused on OHDSI Studies. Leads from six different network studies provided presentations on work happening around the community. Videos/slides from all presentations are available below.
Updates and Shoutouts
• Congratulations to the team of Jimyung Park, Seng Chan You, Eugene Jeong, Chunhua Weng, Dongsu Park, Jin Roh, Dong Yun Lee, Jae Youn Cheong, Jin Wook Choi, Mira Kang, and Rae Woong Park for this recent study in JMIR Informatics: A Framework (SOCRATex) for Hierarchical Annotation of Unstructured Electronic Health Records and Integration Into a Standardized Medical Database: Development and Usability Study.
• Congratulations to the team of Hao Liu, Yuan Chi, Alex Butler, Yingcheng Sun, Chunhua Weng for this study published in the Journal of Biomedical Informatics: A Knowledge Base of Clinical Trial Eligibility Criteria.
• Congratulations to Clair Blacketer, Frank DeFalco, Patrick Ryan and Peter Rijnbeek on this recent preprint posted to MedRxiv: Increasing Trust in Real-World Evidence Through Evaluation of Observational Data Quality. Community feedback is appreciated.
• Patrick Ryan shared this forum post asking for community feedback on the recent FDA/CBER draft master protocol for their COVID-19 vaccine safety surveillance efforts. Leaders of our OHDSI team working with the FDA will collate responses and provide a collective response from the community. Please share all feedback by midnight Wednesday, as public response is due Thursday. You can post to the thread, or in the EUMAEUS channel within the PLE/PLP team.
• The next OHDSI APAC Community Call will be this week and will focus on OMOP Projects. Scheduled presenters will be Yuan Lu (Comprehensive comparative effectiveness and safety of second-line antihypertensive agents: Utilizing the LEGEND principles to mobilize collaboration across the OHDSI APAC network) and Namki Hong (Development of Common Data Model for Rare Endocrine Diseases (REDCDM) platform). More information is available on our OHDSI APAC webpage.
• The April edition of “The Journey” newsletter was posted last week, and links to all of the papers and preprints discussed on the community calls over the last month, as well as updates on OHDSI work with the FDA, the new collaboration with HL7, advances in patient-level prediction, and much more.
2:10 – Cancer Risk Between H2 Blockers (Seng Chan You)
7:33 – MSKAI- Musculoskeletal adverse events following hormonal treatment for breast cancer: Cohort Diagnostics to establish feasibility (Jenny Lane)
14:15 – Covid-19 pandEmic impacts on mental health Related conditions Via multi-database nEtwork: a LongitutinaL Observational (CERVELLO) study (Carmen Olga-Torre)
19:33 – Alpha-1 blocker for Palliating Inflammatory injury Severity (APIS) study (Aki Nishimura)
25:33 – Calculating the background rates of adverse events of special interest (AESI) for the COVID vaccines (Xintong Li)
33:11 – EUMAEUS – Evaluating Use of Methods for Adverse Event Under Surveillance (Martijn Schuemie)